Southland Q2 FY26 net loss more than doubled to $84.3 million; revenue drops 47.4% to $113.3 million

Reuters2026/08/12 21:17

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Southland Holdings posted Q2 revenue of $113.3 million, down 47.4% from the year-earlier quarter.
Net loss attributable to stockholders widened to $84.3 million, or $(1.55) per share, from $(0.19) per share.
Gross loss deepened to $71.2 million, swinging from gross profit a year earlier; gross margin fell 68.9 percentage points to (62.9)%.
EBITDA turned to a loss of $73.4 million from $4.2 million.
Management cited unfavorable non-cash legacy-dispute adjustments, while pursuing financing and credit amendments; backlog stood at $1.68 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Southland Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260812765830) on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经•2026/09/14 00:46

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Reuters•2026/09/14 00:39

Oman postpones the meeting originally scheduled for the 14th with Iran and other countries; the US warns: Don't expect a breakthrough in the Strait of Hormuz

华尔街见闻•2026/09/14 00:23